Kozak & Associates, Inc. Abb Vie Inc. Transaction History
Kozak & Associates, Inc.
- $397 Million
- Q2 2024
A detailed history of Kozak & Associates, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Kozak & Associates, Inc. holds 1,471 shares of ABBV stock, worth $241,008. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,471
Previous 1,471
-0.0%
Holding current value
$241,008
Previous $267,000
5.62%
% of portfolio
0.06%
Previous 0.07%
Shares
10 transactions
Others Institutions Holding ABBV
# of Institutions
3,653Shares Held
1.24BCall Options Held
15.5MPut Options Held
11.6M-
Vanguard Group Inc Valley Forge, PA170MShares$27.9 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY143MShares$23.4 Billion0.61% of portfolio
-
State Street Corp Boston, MA78MShares$12.8 Billion0.64% of portfolio
-
Jpmorgan Chase & CO New York, NY51.3MShares$8.4 Billion0.85% of portfolio
-
Capital International Investors Los Angeles, CA48.1MShares$7.88 Billion1.81% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $290B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...